🚀 VC round data is live in beta, check it out!

Klea Valuation Multiples

Discover revenue and EBITDA valuation multiples for Klea and similar public comparables like Optomed, InspireMD, BATM Advanced Communications, Cyclopharm and more.

Start Free Trial See companies similar to Klea

Jump to Section

Klea Overview

About Klea

Klea Holding focused on the acquisition, development and digitalization of companies in multiple sectors. Its development of Smart Salem, the first network of digital medical analysis centers accredited by the Dubai Ministry of Health (DHA) in the Emirates United Arabs, or its Smart Health joint venture developed in Saudi Arabia.

Founded

2007

HQ

Employees

123

Website

kleaholding.com

Sectors

Medical Devices Medical Imaging & Diagnostics

Financials (FY)

Revenue: $20M

EBITDA: $5M

EV

$65M

Valuation Multiples

Multiples.vc

Start free trial

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 230 more verticals.

Browse Valuation Multiples

Klea Financials

Klea reported last fiscal year revenue of $20M and EBITDA of $5M.

In the same fiscal year, Klea generated $10M in gross profit, $5M in EBITDA, and $2M in net income.

Klea P&L

In the most recent fiscal year, Klea reported revenue of $20M and EBITDA of $5M.

Klea expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Klea forward-looking valuation multiples

	LTM	NTM	Last FY	FY 2026	FY 2027	FY 2028
Revenue	—	XXX	$20M	XXX	XXX	XXX
Gross Profit	—	XXX	$10M	XXX	XXX	XXX
Gross Margin	—	XXX	48%	XXX	XXX	XXX
EBITDA	—	XXX	$5M	XXX	XXX	XXX
EBITDA Margin	—	XXX	23%	XXX	XXX	XXX
EBIT Margin	—	XXX	11%	XXX	XXX	XXX
Net Profit	—	XXX	$2M	XXX	XXX	XXX
Net Margin	—	XXX	8%	XXX	XXX	XXX
Net Debt	—	—	$3M	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

Klea Stock Performance

Klea has current market cap of $63M, and enterprise value of $65M.

Market Cap Evolution

Klea's stock price is $0.21.

See Klea trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$65M	$63M	-1.0%	XXX	XXX	XXX	$0.01

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Klea Valuation Multiples

Klea trades at 3.2x EV/Revenue multiple, and 14.3x EV/EBITDA.

See valuation multiples for Klea and 15K+ public comps

Klea Financial Valuation Multiples

As of April 19, 2026, Klea has market cap of $63M and EV of $65M.

Equity research analysts estimate Klea's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Klea has a P/E ratio of 38.3x.

	LTM	NTM	Last FY	FY 2026	FY 2027	FY 2028
Market cap (current)	$63M	XXX	$63M	XXX	XXX	XXX
EV (current)	$65M	XXX	$65M	XXX	XXX	XXX
EV/Revenue	—	XXX	3.2x	XXX	XXX	XXX
EV/EBITDA	—	XXX	14.3x	XXX	XXX	XXX
EV/EBIT	—	XXX	28.6x	XXX	XXX	XXX
EV/Gross Profit	—	XXX	6.7x	XXX	XXX	XXX
P/E	—	XXX	38.3x	XXX	XXX	XXX
EV/FCF	—	XXX	335.1x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Klea Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

Start Free Trial

Klea Margins & Growth Rates

Klea's revenue in the last fiscal year grew by 26%.

Klea's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.

See operational valuation multiples for Klea and other 15K+ public comps

Klea Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2026	FY 2027	FY 2028
Revenue Growth	—	XXX	26%	XXX	XXX	XXX
EBITDA Margin	—	XXX	23%	XXX	XXX	XXX
EBITDA Growth	—	XXX	(34%)	XXX	XXX	XXX
Revenue per Employee	—	XXX	$0.2M	XXX	XXX	XXX
Opex per Employee	—	XXX	$0.1M	XXX	XXX	XXX
Opex to Revenue	—	XXX	37%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across vertical AI apps, GRC software, cloud infrastructure, DevOps, marketplaces and many more.

Digital Therapeutics Horizontal Marketplaces Investment Banking ERP Software Developer Tools Consumer SaaS Streaming Vertical SaaS Networking Hardware Financial Data & Information Energy Storage Road Infrastructure Semiconductors

Explore Valuation Multiples by Industry

Klea Public Comps

See public comps and valuation multiples for other Medical Devices and Medical Imaging & Diagnostics comps.

	EV/Revenue			EV/EBITDA
	LTM	2026E	2027E	LTM	2026E	2027E
Klea	XXX	XXX	XXX	XXX	XXX	XXX
Optomed	XXX	XXX	XXX	XXX	XXX	XXX
InspireMD	XXX	XXX	XXX	XXX	XXX	XXX
BATM Advanced Communications	XXX	XXX	XXX	XXX	XXX	XXX
Cyclopharm	XXX	XXX	XXX	XXX	XXX	XXX
Baird Medical Investment	XXX	XXX	XXX	XXX	XXX	XXX
XXXXXXXX	XXX	XXX	XXX	XXX	XXX	XXX
XXXXXXXX	XXX	XXX	XXX	XXX	XXX	XXX

Valuation data powered by FactSet, Inc.

Klea M&A Activity

Klea acquired XXX companies to date.

Last acquisition by Klea was on XXXXXXXX, XXXXX. Klea acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See M&A valuation multiples

Latest Acquisitions by Klea

Acquired Company	Valuation	EV/Revenue	EV/EBITDA
XXXXXXXXXXXX	XXX	XXX	XXX
XXXXXXXXXXXX	XXX	XXX	XXX
XXXXXXXXXXXX	XXX	XXX	XXX
XXXXXXXXXXXX	XXX	XXX	XXX
XXXXXXXXXXXX	XXX	XXX	XXX

Get Verified M&A Valuation Multiples

Start Free Trial

Klea Investment Activity

Klea invested in XXX companies to date.

Klea made its latest investment on XXXXXXXX, XXXXX. Klea invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See VC round multiples

Latest Investments by Klea

Company	Valuation	EV/Revenue	EV/EBITDA
XXXXXXXXXXXX	XXX	XXX	XXX
XXXXXXXXXXXX	XXX	XXX	XXX
XXXXXXXXXXXX	XXX	XXX	XXX
XXXXXXXXXXXX	XXX	XXX	XXX
XXXXXXXXXXXX	XXX	XXX	XXX

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Klea

When was Klea founded?	Klea was founded in 2007.
Where is Klea headquartered?	Klea is headquartered in France.
How many employees does Klea have?	As of today, Klea has over 123 employees.
Is Klea publicly listed?	Yes, Klea is a public company listed on Euronext Paris.
What is the stock symbol of Klea?	Klea trades under ALKLH ticker.
When did Klea go public?	Klea went public in 2011.
Who are competitors of Klea?	Klea main competitors are Optomed, InspireMD, BATM Advanced Communications, Cyclopharm.
What is the current market cap of Klea?	Klea's current market cap is $63M.
What is the current revenue of Klea?	Klea's last fiscal year revenue is $20M.
What is the current EV/Revenue multiple of Klea?	Current revenue multiple of Klea is 3.2x.
Is Klea profitable?	No, Klea is not profitable.

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial

Klea Valuation Multiples

Discover revenue and EBITDA valuation multiples for Klea and similar public comparables like Optomed, InspireMD, BATM Advanced Communications, Cyclopharm and more.

Klea Overview

About Klea

Founded

HQ

Employees

Website

Sectors

Financials (FY)

EV

Valuation Multiples

Valuation Multiples for 15K+ Public Comps

Klea Financials

Klea P&L

Klea Stock Performance

Market Cap Evolution

Benchmark Trading Valuation Multiples by Industry

Klea Valuation Multiples

Klea Financial Valuation Multiples

Verified Klea Valuation Multiples

Klea Margins & Growth Rates

Klea Operational Valuation Multiples

Valuation Multiples Across 230+ Verticals

Klea Public Comps

Klea M&A Activity

Latest Acquisitions by Klea

Get Verified M&A Valuation Multiples

Klea Investment Activity

Latest Investments by Klea

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

About Klea

Start Your Free Trial Today

Start Your
Free Trial Today